Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
67,6 ILa | +7,47% | +8,51% | +101,79% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Abraham Dreazen
CEO | Chief Executive Officer | 40 | 12-08-20 |
Ishai Gandelsman
DFI | Director of Finance/CFO | 61 | 10-07-22 |
General Counsel | 53 | 12-08-20 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 01-01-94 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yaacov Elinav
BRD | Director/Board Member | 79 | 12-08-20 |
Israel Makov
CHM | Chairman | 85 | 21-11-11 |
Ron Grupel
BRD | Director/Board Member | 73 | 13-10-14 |
Jakob Ripshtein
BRD | Director/Board Member | 57 | 12-08-20 |
Orna Dreazen
BRD | Director/Board Member | 69 | 12-08-20 |
Director/Board Member | 59 | 12-08-20 | |
Director/Board Member | 72 | 12-08-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 33 268 639 | 5 146 509 ( 15,47 %) | 0 | 15,47 % |
Bedrijfsgegevens
NEXTAGE Therapeutics Ltd.
Einstein Street, Building 13B Weizmann Science Park
7403617, Ness Ziona
+
http://www.nxtg.co.ilSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+101,79% | 6,06 mln. | |
-38,56% | 8,39 mld. | |
+0,18% | 3,32 mld. | |
+9,29% | 2,49 mld. | |
-18,21% | 2,06 mld. | |
-24,57% | 1,59 mld. | |
+32,37% | 1,15 mld. | |
-7,64% | 704 mln. | |
+8,42% | 678 mln. | |
-29,59% | 508 mln. |
- Beurs
- Aandelen
- Koers NXTG
- Onderneming Nextage Therapeutics Ltd